Literature DB >> 29306116

Incorporation of the chemotherapy medication cisplatin into polyamide membrane.

Érica A de Souza1, Lucas A Rocha1, Emerson H de Faria1, Katia J Ciuffi1, Eduardo J Nassar2, Jorge V L Silva3, Marcelo F Oliveira3, Izaque A Maia3.   

Abstract

The search for more efficient and less aggressive cancer treatment methods has intensified over the last decades and has involved many scientific areas. To provide skin cancer patients with better quality of life, this work aims to incorporate chemotherapy into polyamide membranes, functionalized by the sol-gel methodology, for controlled drug release at the target tissue. A 200-micrometer-thick flexible polyamide membrane prepared by Additive Manufacture was activated and functionalized with the alkoxide 3-chloropropyltriethoxysilane, which was followed by incorporation of the antitumor agent cisplatin. Membrane functionalization with the alkoxide was attested by infrared absorption spectroscopy, which evidenced a band at 1100cm-1, due to Si-O-Si vibration, and typical cisplatin bands at 3200 and 1600cm-1. The thermogravimetric curve revealed increased silicon oxide and platinum residues. Drug release was tested in simulated body fluid. Cytotoxicity was evaluated by the Cell Proliferation Kit, which gave IC50 of 23.95μgM.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Additive manufacturing; Cytotoxicity; Functionalization; Sol–gel

Mesh:

Substances:

Year:  2017        PMID: 29306116     DOI: 10.1016/j.jinorgbio.2017.12.013

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  1 in total

1.  Silver nanoparticle incorporation into flexible polyamide 12 membranes.

Authors:  Maria Gabriela Martins de Souza; Jéssica Potomatti Batista; Emerson Henrique de Faria; Katia Jorge Ciuffi; Lucas Alonso Rocha; Eduardo José Nassar; Jorge Vicente Lopes da Silva; Marcelo Fernandes Oliveira; Izaque Alves Maia
Journal:  J Solgel Sci Technol       Date:  2022-01-20       Impact factor: 2.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.